SUDAFED PE SEVERE COLD OTC
Generic Name and Formulations:
Acetaminophen 325mg, diphenhydramine HCl 12.5mg, phenylephrine HCl 5mg; per caplet.
McNeil Consumer Healthcare
Indications for SUDAFED PE SEVERE COLD:
Nasal congestion, rhinorrhea, headache, sore throat, fever.
2 caplets every 4hrs as needed; max 12 caplets/24hrs.
<6yrs: individualize. 6–11yrs: 1 caplet every 4hrs as needed; max 5 caplets/24hrs.
Within 14 days of MAOIs. Concomitant acetaminophen or diphenhydramine (including topical) products.
Cardiovascular disease. Hypertension. Liver disease. Thyroid disease. Glaucoma. Diabetes. Asthma. Lower respiratory disorders. GI or GU obstruction.
See Contraindications. Increased risk of liver damage with ≥3 alcoholic drinks/day. Hypertensive crisis with MAOIs. β-blockers may increase the pressor effects of sympathomimetics. Other CNS depressants potentiated. Antihypertensives antagonized.
Analgesic + antihistamine + sympathomimetic.
Drowsiness, anticholinergic effects, nervousness, dizziness, insomnia, excitability in children.
Severe Cold—12, 24
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Immune Checkpoint Inhibitors for NSCLC: Current and Future Approaches
- Can A Consortium of Hospitals Help To Reduce Drug Prices?
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Erdafitinib Granted FDA Breakthrough Therapy Designation for Urothelial Carcinoma
- NSCLC: Stratifying Patients With Complex EGFR Mutations
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma
- NSCLC: Pretreatment Weight Loss May Be Linked to Socioeconomic Status
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC
- Model May Identify Patients With Gastric Cancer Likely To Benefit From Chemotherapy